Living with a movement disorder like Parkinson’s means being prepared and planning ahead. That includes visits to your medical team. Movement disorder neurologist Deborah Boland,…
Adamas Announces Publication of the Two-Year Phase 3 Open-Label EASE LID 2 Trial of GOCOVRI® for Dyskinesia in Patients with Parkinson’s Disease. Sometimes the dyskinesia…
One of the important factors for getting a smooth response from your Parkinson disease (PD) medications is recognizing the signs and symptoms of PD that…
Soft voice, frozen feet, shuffling gait, stiffness – the list of challenges that people with Parkinson’s face goes on and on. Medication can help. Exercise…
In 2015 researchers discovered that the prodrug DHED that selectively delivers 17β-estradiol to the brain for treating estrogen responsive disorder, halted or slowed down the…
The final week of August brought two new FDA approvals for Parkinson's medications. MYOBLOC (rimabotulinumtoxinB) - a botulinum toxin type B, was indicated for the treatment of chronic…
Restless Leg Syndrome (RLS), is a neurological disorder that results in an uncontrollable urge to move one's legs. This syndrome typically can disrupt an individual's…